|
Cefiderocol
|
Other cephalosporins
|
15-Aug-2023 |
|
Cefepime (injection)
|
Fourth generation cephalosporins
|
15-Aug-2023 |
|
Cefditoren
|
Third generation cephalosporins
|
15-Aug-2023 |
|
Cefazolin (injection)
|
First generation cephalosporins
|
15-Aug-2023 |
|
Cefadroxil
|
First generation cephalosporins
|
15-Aug-2023 |
|
Calcium carbonate, famotidine, and magnesium hydroxide
|
H2 antagonists
|
15-Aug-2023 |
|
Calcium carbonate and magnesium hydroxide
|
Antacids
|
15-Aug-2023 |
|
Calcium carbonate and magnesium chloride
|
Minerals and electrolytes
|
15-Aug-2023 |
|
Calcium and vitamin d combination
|
Vitamin and mineral combinations
|
15-Aug-2023 |
|
Calcium acetate
|
Minerals and electrolytes
|
15-Aug-2023 |
|
Calcium 500+d
|
Vitamin and mineral combinations
|
15-Aug-2023 |
|
Calcitriol (topical)
|
Topical antipsoriatics
|
15-Aug-2023 |
|
Calcitonin nasal
|
Calcitonin
|
15-Aug-2023 |
|
Calcitonin injection
|
Calcitonin
|
15-Aug-2023 |
|
Calcitonin (monograph)
|
Drugs
|
15-Aug-2023 |
|
Calcipotriene topical
|
Topical antipsoriatics
|
15-Aug-2023 |
|
Calcifediol
|
Vitamins
|
15-Aug-2023 |
|
Calaspargase pegol
|
Miscellaneous antineoplastics
|
15-Aug-2023 |
|
Calanolide a
|
Drugs
|
15-Aug-2023 |
|
Calamine (topical)
|
Miscellaneous topical agents
|
15-Aug-2023 |
|
Caffeine/caffeine and sodium benzoate (monograph)
|
Drugs
|
15-Aug-2023 |
|
Caffeine citrate (injection/oral liquid)
|
CNS stimulants
|
15-Aug-2023 |
|
Caffeine
|
CNS stimulants
|
15-Aug-2023 |
|
Caffeine and ergotamine (oral/rectal)
|
Antimigraine agents
|
15-Aug-2023 |
|
Cabozantinib
|
Multikinase inhibitors
|
15-Aug-2023 |
|
Cabotegravir and rilpivirine
|
Antiviral combinations
|
15-Aug-2023 |
|
Cabotegravir
|
Integrase strand transfer inhibitor
|
15-Aug-2023 |
|
Budesonide nasal
|
Nasal steroids
|
15-Aug-2023 |
|
Budesonide inhalation
|
Glucocorticoids
|
15-Aug-2023 |
|
Budesonide and formoterol (inhalation)
|
Bronchodilator combinations
|
15-Aug-2023 |
|
Budesonide (systemic, oral inhalation) (monograph)
|
Drugs
|
15-Aug-2023 |
|
Brompheniramine, dextromethorphan, and pseudoephedrine
|
Upper respiratory combinations
|
15-Aug-2023 |
|
Brompheniramine, dextromethorphan, and phenylephrine
|
Upper respiratory combinations
|
15-Aug-2023 |
|
Brompheniramine, codeine, and phenylephrine
|
Upper respiratory combinations
|
15-Aug-2023 |
|
Brompheniramine, chlorpheniramine, methscopolamine, phenylephrine, and pseudoephedrine
|
Upper respiratory combinations
|
15-Aug-2023 |
|
Brompheniramine and pseudoephedrine
|
Upper respiratory combinations
|
15-Aug-2023 |
|
Brompheniramine and phenylephrine
|
Upper respiratory combinations
|
15-Aug-2023 |
|
Bromocriptine
|
Dopaminergic antiparkinsonism agents
|
15-Aug-2023 |
|
Bromo seltzer
|
Drugs
|
15-Aug-2023 |
|
Bromfenac (ophthalmic)
|
Ophthalmic anti-inflammatory agents
|
15-Aug-2023 |
|
Brolucizumab ophthalmic
|
Anti-angiogenic ophthalmic agents
|
15-Aug-2023 |
|
Brolucizumab (monograph)
|
Drugs
|
15-Aug-2023 |
|
Brodalumab
|
Interleukin inhibitors
|
15-Aug-2023 |
|
Brivaracetam (oral/injection)
|
Pyrrolidine anticonvulsants
|
15-Aug-2023 |
|
Brivaracetam (monograph)
|
Drugs
|
15-Aug-2023 |
|
Brinzolamide ophthalmic
|
Ophthalmic glaucoma agents
|
15-Aug-2023 |
|
Brimonidine topical
|
Topical anti-rosacea agents
|
15-Aug-2023 |
|
Brimonidine ophthalmic
|
Ophthalmic glaucoma agents
|
15-Aug-2023 |
|
Brimonidine and timolol ophthalmic
|
Ophthalmic glaucoma agents
|
15-Aug-2023 |
|
Brimonidine and brinzolamide ophthalmic
|
Ophthalmic glaucoma agents
|
15-Aug-2023 |
|
Brimonidine (eent) (monograph)
|
Drugs
|
15-Aug-2023 |
|
Brigatinib
|
Multikinase inhibitors
|
15-Aug-2023 |
|
Brexucabtagene autoleucel
|
Miscellaneous antineoplastics
|
15-Aug-2023 |
|
Brexpiprazole
|
Atypical antipsychotics
|
15-Aug-2023 |
|
Brexanolone
|
Miscellaneous antidepressants
|
15-Aug-2023 |
|
Brentuximab vedotin
|
CD30 monoclonal antibodies
|
15-Aug-2023 |
|
Bremelanotide
|
Melanocortin receptor agonists
|
15-Aug-2023 |
|
Brantussin dm
|
Upper respiratory combinations
|
15-Aug-2023 |
|
Bacopa
|
Drugs
|
15-Aug-2023 |
|
Bp vit 3
|
Nutraceutical products
|
15-Aug-2023 |
|
Bp allergy jr
|
Upper respiratory combinations
|
15-Aug-2023 |
|
Botulism immune globulin
|
Immune globulins
|
15-Aug-2023 |
|
Botulism antitoxin (equine) (monograph)
|
Drugs
|
15-Aug-2023 |
|
Bosutinib
|
BCR-ABL tyrosine kinase inhibitors
|
15-Aug-2023 |
|
Bosentan
|
Agents for pulmonary hypertension
|
15-Aug-2023 |
|
Bortezomib
|
Proteasome inhibitors
|
15-Aug-2023 |
|
Borage
|
Drugs
|
15-Aug-2023 |
|
Boneset
|
Drugs
|
15-Aug-2023 |
|
Bocasal
|
Mouth and throat products
|
15-Aug-2023 |
|
B & o supprettes 16-a (rectal)
|
Narcotic analgesic combinations
|
15-Aug-2023 |
|
B & o supprettes 15-a (rectal)
|
Narcotic analgesic combinations
|
15-Aug-2023 |
|
Betamethasone (injection)
|
Glucocorticoids
|
15-Aug-2023 |
|
Betamethasone and clotrimazole topical
|
Topical steroids with anti-infectives
|
15-Aug-2023 |
|
Betamethasone (systemic) (monograph)
|
Drugs
|
15-Aug-2023 |
|
Betaine
|
Nutraceutical products
|
15-Aug-2023 |
|
Betadine ophthalmic solution
|
Ophthalmic anti-infectives
|
15-Aug-2023 |
|
Beta-glucan
|
Drugs
|
15-Aug-2023 |
|
Besifloxacin ophthalmic
|
Ophthalmic anti-infectives
|
15-Aug-2023 |
|
Berotralstat
|
Hereditary angioedema agents
|
15-Aug-2023 |
|
Bergamot juice
|
Drugs
|
15-Aug-2023 |
